Inverted Fab2s (IFab2s): Engineering and expression of novel, dimeric molecules, with a molecular weight of 100000

Molecular Immunology

Volumn 33, Issue 14, 1997, Pages 1095-1102

  Speck, R Renae ^a   Couto, Joseph R ^a   Godwin, Simon G ^a   Christian, Rosemarie B ^a   Kiwan, Radwan ^a   Ceriani, Roberto L ^a   Peterson, Jerry A ^a  

^a Cancer Research Fund of Contra Costa   (United States)

Author keywords

antibody engineering; antibody fragments; F(ab)'2; IFab2; radioimmunotherapy

Indexed keywords

CANCER ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY;

ANTIBODY AFFINITY; ARTICLE; BREAST CANCER; DNA SEQUENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; B-LYMPHOCYTES; BASE SEQUENCE; BINDING, COMPETITIVE; BIOPOLYMERS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MOLECULAR SEQUENCE DATA; MUCINS; PROTEIN ENGINEERING;

EID: 0030268054     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00063-6     Document Type: Article

References (35)

1. Berzofsky J. A. and Berkower I. J. (1984) Antigen-antibody interaction. In Fundamental Immunology (Edited by Paul W. E.) pp. 595-619. Raven Press, New York.
2. Blank E. W., Pant K. D., Chan C. M., Peterson J. A. and Ceriani R. L. (1992) A novel anti-breast epithelial mucin mAb (BrE-3). Characterization and experimental biodistribution and immunotherapy. J. Cancer 5, 38-44.
3. Brizzard B. L., Chubet R. G. and Vizard D. L. (1994) Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. Biotechniques 16, 730-735.
4. Buchegger F., Haskell C. M., Schreyer M., Scazziga B. R., Randin S., Carrel S. and Mach J. P. (1983) Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J. Exp. Med. 158, 413-427.
5. Ceriani R. L., Blank E. W., Couto J. R. and Peterson J. A. (1995) Biological activity of two humanized antibodies against two different breast cancer antigens and comparison to their murine original forms. Cancer Res. 55, 5852s-5856s.
6. Ceriani R. L., Peterson J. A., Lee J. Y., Moncada R. and Blank E. W. (1983) Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet. 9, 415-427.
7. Ceriani R. L., Thompson K., Peterson J. A. and Abraham S. (1977) Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc. natn. Acad. Sci. U.S.A. 74, 582-586.
8. Colcher D., Zalutsky M., Kaplan W., Kufe D., Austin F. and Schlom J. (1983) Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res. 43, 736-742.
9. Coloma M. J., Hastings A., Wims L. A. and Morrison S. L. (1992) Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J. Immun. Meth. 152, 89-104.
10. Couto J. R., Blank E. W., Peterson J. A. and Ceriani R. L. (1993) Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody. Hybridoma 12, 15-23.
11. Couto J. R., Blank E. W., Peterson J. A., Kiwan R., Padlan E. A. and Ceriani R. L. (1994). Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of murine monoclonal antibody BrE-3. In Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment (Edited by Ceriani R. L.), pp. 55-59. Plenum Press, New York.
12. Covell D. G., Barbet J., Holton O. D., Black C. D., Parker R. J. and Weinstein J. N. (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)2, and Fab′ in mice. Cancer Res. 46, 3969-3978.
13. Delaloye A. B. and Delaloye B. (1995) Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion? Eur. J. Nuc. Med. 22, 571-580.
14. Dykes P. W., Bradwell A. R., Chapman C. E. and Vaughan A. T. (1987) Radioimmunotherapy of cancer: clinical studies and limiting factors. Cancer Treat. Rev. 14, 87-106.
15. Jain R. K. (1990) Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res. 50, 814s-819s.
16. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S. and Foeller C. (1991) Sequences of Proteins of Immunological Interest, 5th Edition, Volume publication No. 91-3242.: U.S. Department of Health and Human Services and NIH.
17. Knox S. J. (1995) Overview of studies on experimental radioimmunotherapy. Cancer Res. 55, 5832s-5836s.
18. Kramer E. L., DeNardo S. J., Liebes L., Kroger L. A., Noz M. E., Mizrachi H., Salako Q. A., Furmanski P., Glenn S. D., DeNardo G. L. and Ceriani R. (1993) Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J. Nuc. Med. 34, 1067-1074.
19. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. Lanzavecchia A. and Scheidegger D. (1987) The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur. J. Immun. 17, 105-111.
21. Milenic D. E., Esteban J. M. and Colcher D. (1989) Comparison of methods for the generation of immunoreactive fragments of a monoclonal antibody (B72.3) reactive with human carcinomas. J. Immun. Meth. 120, 71-83.
22. Milenic D. E., Yokota T., Filpula D. R., Finkelman M. A., Dodd S. W., Wood J. F., Whitlow M., Snoy P. and Schlom J. (1991) Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363-6371.
23. Motta-Hennessy C., Sharkey R. M. and Goldenberg D. M. (1990) Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. J. Nuc. Med. 31, 1510-1519.
24. Padlan E. A. (1994) Anatomy of the antibody molecule. Mol. Immun. 31, 161-217.
25. Peterson J. A., Couto J. R., Taylor M. R. and Ceriani R. L. (1995) Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Cancer Res. 55, 5847s-5851s.
26. Peterson J. A., Zava D. T., Duwe A. K., Blank E. W., Battifora H. and Ceriani R. L. (1990) Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule. Hybridoma 9, 221-235.
27. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning, A Laboratory Manual, 2nd Edition. CSH Lab. Press, Cold Spring Harbor.
28. Schrier D. M., Stemmer S. M., Johnson T., Kasliwal R., Lear J., Matthes S., Taffs S., Dufton C., Glenn S. D., Butchko G., Ceriani R. L., Rovira D., Bunn P., Shpall E. J., Bearman S. I., Purdy M., Cagnoni P. and Jones R. B. (1995) High-dose 90-YMx-DTPA-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase 1 trial. Cancer Res. 55, 5921s-5924s.
29. Sfakianakis G. N., Garty I. I. and Serafini A. N. (1990) Radioantibodies for the diagnosis and treatment of cancer; radioimmunoimaging (RAI) and radioimmunotherapy (RAT). Cancer Invest. 8, 381-405.
30. Sharkey R. M., Motta-Hennessy C., Pawlyk D., Siegel J. A. and Goldenberg D. M. (1990) Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. Cancer Res. 50, 2330-2336.
31. Shulman M., Wilde C. D. and Kohler G. (1978) A better cell line for making hybridomas secreting specific antibodies. Nature 276, 269-270.
32. Wessels B. W. (1990) Current status of animal radioimmunotherapy. Cancer Res. 50, 970s-973s.
33. Yokota T., Milenic D. E., Whitlow M. and Schlom J. (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402-3408.
34. Yokota T., Milenic D. E., Whitlow M., Wood J. F., Hubert S. L. and Schlom J. (1993) Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Cancer Res. 53, 3776-3783.
35. Zalcberg J. R., Thompson C. H., Lichtenstein M., Andrews J. and McKenzie I. F. (1983) Localization of human colorectal tumor xenografts in the nude mouse with the use of radiolabeled monoclonal antibody. J. natn. Cancer Inst. 71, 801-808.